Portable Diagnostic Devices Market Size

ID: MRFR/HC/5752-CR

128 Pages

Kinjoll Dey

September 2023

Portable Diagnostic Devices Market Research Report Information By Type (Diagnostic Imaging and Monitoring Devices) by Application (Gynecology, Cardiology, Gastrointestinal, Urology, Neurology, Respiratory, Orthopedics, Ophthalmology, And Others), By End User (Hospitals & Clinics, Diagnostic Centers, Homecare Setting And Other) by Region (North America, Europe, Asia-Pacific, and Rest of the ...

Portable Diagnostic Devices Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Portable Diagnostic Devices Size

Portable Diagnostic Devices Market Growth Projections and Opportunities

Increased point-of-care diagnostic will impact portable diagnostic equipment sales. Healthcare workers and patients are embracing portable diagnostic devices for rapid examinations. These devices save time and effort in lab diagnostic . Technology continuously impacts the microscopic diagnostic equipment business. Better connections, sensors, and smaller diagnostic equipment are driving the industry. These developments have made portable diagnostic equipment more accurate and helpful, therefore doctors are interested in them. Globally rising chronic illnesses including diabetes, heart disease, and infectious diseases drive the market. Chronic illness monitoring and management are easier with portable diagnostic instruments, helping patients regain control. Condensed diagnostic tools are required more than ever owing to the trend above. Healthcare professionals and people are realizing the advantages of early detection and monitoring, making portable diagnostic devices more popular. Improvements to healthcare facilities, particularly in developing countries, enhance the business. It expands public access to these devices. Market shift toward private healthcare is significant. Portable health diagnostic gadgets reduce hospital visits by letting people check their health at home. The patient-centered care movement widens the market and enhances patient experience. Market orientation is based on portable diagnostic equipment's time and money savings. These devices may replace conventional diagnostic methods without costing much, making them appealing in low-resource settings. Small technologies let physicians make judgments swiftly with their outcomes. Business-friendly government policies influence portable diagnostic equipment. These devices are made and utilized owing to financial incentives, public-private collaborations, and laws. These efforts grow markets. As global health issues like COVID-19 grow, rapid and compact diagnostics are crucial. Portable diagnostic technology research and investment are motivated by the need for rapid, convenient diagnostic services. Over time, this tendency will impact the market. Partnerships between corporations and educational institutions and between important market participants disseminate new ideas and grow the market. These initiatives improve portable diagnostic equipment and accessibility. Competition is accelerating the development of portable diagnostic devices. Businesses provide accuracy, user-friendliness, and several connectivity possibilities to stand out. Competition promotes innovation and provides clients with several high-quality portable diagnostic choices.

Portable Diagnostic Devices Market Size Graph

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Global Portable Diagnostic Devices Market was valued at USD 71.86 billion in 2024 and is projected to reach USD 0.00 billion by 2035, growing at a CAGR of 0.00% from 2025 to 2035. The market growth is driven by technological advancements and the increasing prevalence of chronic diseases. Key segments include diagnostic imaging and monitoring devices, with the diagnostic imaging segment expected to dominate and grow the fastest during the forecast period. North America held the largest market share in 2022, supported by high treatment rates and government initiatives for early disease diagnosis.

Key Market Trends & Highlights

The Portable Diagnostic Devices Market is witnessing significant growth due to various factors.

Market Size in 2024: USD 71.86 billion.
Projected Market Size by 2035: USD 0.00 billion.
CAGR from 2025 to 2035: 0.00%.
North America accounted for the largest market share in 2022.

Portable Diagnostic Devices Market

CAGR

0.00%

Market Size & Forecast

2024 Market Size	USD 71.86 Billion
2035 Market Size	USD 0.00 Billion
CAGR (2023-2035)	0.00%
Largest Regional Market Share in 2022	North America

Major Players

Key players include GE Healthcare, F. Hoffmann-La Roche Ltd, Abbott, Medtronic, and Koninklijke Philips N.V.

Market Trends

The growing technological advancements boosts the market growth.

The ongoing evolution of portable diagnostic devices is poised to enhance patient care by enabling timely and accurate health assessments in diverse settings, thereby potentially transforming the landscape of healthcare delivery.

U.S. Food and Drug Administration (FDA)

Portable Diagnostic Devices Market Market Drivers

Technological Advancements

The Global Portable Diagnostic Devices Market Industry experiences substantial growth due to rapid technological advancements. Innovations such as miniaturization of sensors and integration of artificial intelligence enhance the accuracy and efficiency of diagnostic devices. For instance, portable ultrasound devices now offer high-resolution imaging comparable to traditional systems, enabling healthcare providers to make informed decisions at the point of care. This trend is reflected in the market's projected value of 71.0 USD Billion in 2024, indicating a strong demand for cutting-edge portable solutions that improve patient outcomes.

Market Segment Insights

Portable Diagnostic Devices Market Segment Insights

Portable Diagnostic Devices Type Insights

The Portable Diagnostic Devices Market segmentation is based on type, segmented into diagnostic imaging and monitoring devices. The diagnostic imaging is further segmented into CT, X-ray, ultrasound and endoscopes. Furthermore, monitoring devices are segmented into cardiac monitoring, neuromonitoring, respiratory monitoring, ophthalmic monitoring, hemodynamic monitoring systems, vital sign monitors, smart wearable medical device and others. Moreover, cardiac monitoring further bifurcated into Holter monitors, resting ECG system, stress ECG monitors, event monitoring systems, and ECG management systems. Also, neuromonitoring further segmented into EEG machines, EMG machines, ICP monitors, MEG machines, and cerebral oximeters.

Further, respiratory monitoring segment into capnographs, spirometers, and peak flow meters. Lastly ophthalmic monitoring further segmented into fundus cameras, tonometry devices, and others. The diagnostic imaging segment dominated the market in 2021 and is projected to be the fastest growing during the forecast period, 2023-2032.

November 2022: Koninklijke Philips N.V. launched next-generation compact portable ultrasound solution at the Radiological Society of North America (RSNA) aims to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients.

Portable Diagnostic Devices Application Insights

The Portable Diagnostic Devices Market segmentation is based on application segmented into gynecology, cardiology, gastrointestinal, urology, neurology, respiratory, orthopedics, ophthalmology, and others The cardiology segment dominated the market in 2022 and projected to be the fastest-growing during the forecast period, 2023–2032.

Figure 2: PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Portable Diagnostic Devices End User Insights

The Portable Diagnostic Devices Market segmentation is based on end user segmented into hospitals & clinics, diagnostic centers, homecare setting and others. The hospitals and clinics segment dominated the market in 2022 and projected to be the fastest-growing during the forecast period, 2023–2032.

Get more detailed insights about Portable Diagnostic Devices Market Research Report—Global Forecast till 2032

Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Portable Diagnostic Devices market accounted for the largest market share in 2022. This is due to the rising demand for portable devices, high treatment rates, and supportive government initiatives for early diagnosis of diseases is also expected to foster North America’s market growth.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: PORTABLE DIAGNOSTIC DEVICES MARKET SHARE BY REGION 2022 & 2032

PORTABLE DIAGNOSTIC DEVICES MARKET SHARE BY REGION 2022 & 2032

Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

Europe Portable Diagnostic Devices market accounts for the second-largest market share due to the Rising adoption of advanced medical devices, high treatment rates and supportive government initiatives for early disease detection is also expected to support the growth of the market. further, the Germany Portable Diagnostic Devices market was attributed to hold the largest market share, and the UK Portable Diagnostic Devices market is expected to fastest-growing market in the European region.

The Asia-Pacific Portable Diagnostic Devices market is expected to grow at a significant share from 2023 to 2032. This is due to factors such as the rise in the geriatric population, the growing prevalence of diabetes, escalating incidences of heart diseases, and an increase in disposable income along with the adoption of smart wearables is further expected to boost the market growth. Moreover, China Portable Diagnostic Devices market is expected to hold the largest market share, and India Portable Diagnostic Devices market is expected fastest-growing market in the Asia-Pacific region.

The Rest of the World is segmented into the Middle East, Africa, and Latin America. The portable diagnostic devices market in the above-mentioned regions is likely to witness growth due to Increasing demand for innovative imaging modalities and increase in cases of chronic diseases drive the growth of the Portable Diagnostic Devices market in the Rest of the World.

Key Players and Competitive Insights

The Portable Diagnostic Devices Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as include GE Healthcare, F. Hoffmann-La Roche Ltd, Abbott, Medtronic, and Koninklijke Philips N.V. among others, dominate the Portable Diagnostic Devices Market due to product differentiation, financial stability, strategic developments, and diversified regional presence.

The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

One of the primary business strategies adopted by manufacturers in the global portable diagnostic devices industry to benefit clients and expand the portable diagnostic devices market sector is to manufacture locally to reduce operating costs.

Hoffmann-La Roche Ltd (Roche) is one of the leading companies in the field of diagnostics and pharmaceuticals. It develops and markets products for the diagnosis & treatment of anemia, cancer, anticoagulation therapy, cardiovascular diseases, diabetes, central nervous system, chlamydia, dermatology, gonorrhea, gout, hepatitis B and C, hemostasis disorders, HIV/AIDS, HPV, infectious diseases, and autoimmune diseases. The company supplies in-vitro diagnostics and drugs for cancer and transplantation. Moreover, it specializes in the field of molecular diagnostics and medicines for oncology, virology, inflammation, metabolism, central nervous system (CNS), clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. In addition, the company has offices and subsidiaries throughout the Americas, Europe, the Middle East, Africa, and Asia-Pacific.

Also, GE Healthcare is part of the General Electric Company. The company's products are sold worldwide, primarily to hospitals, medical facilities, pharmaceutical and biotechnology companies, and the life science research industry. The company provides healthcare technologies in medical imaging, digital solutions, patient monitoring, diagnostics, drug discovery, biopharmaceutical manufacturing technologies, and performance enhancement solutions. General Electric Company has a strong presence in the global market in more than 160 countries.

Key Companies in the Portable Diagnostic Devices Market market include

Industry Developments

January 2021: Koninklijke Philips N.V. introduced Lumify portable smart device ultrasound solution in Japan to enable powerful diagnostics at the medical centers.

February 2021: Koninklijke Philips N.V. launched portable monitoring kit for remote patient management. The new Philips Medical Tablet is an end-to-end, easy-to-implement kit which has been designed to support clinicians to remotely monitor larger patient populations during emergency situations such as Covid-19 pandemic.

May 2022: GE Healthcare (US) and Alliance Medical (UK), collaborated to improve patient access to diagnostics and enhance radiology productivity using data analytics and AI.

Future Outlook

Portable Diagnostic Devices Market Future Outlook

The Portable Diagnostic Devices Market is projected to grow at a 9.55% CAGR from 2024 to 2034, driven by technological advancements, increasing demand for home healthcare, and rising chronic disease prevalence.

New opportunities lie in:

Develop AI-driven diagnostic tools for real-time patient monitoring.
Expand product lines to include portable devices for remote patient management.
Invest in partnerships with telehealth platforms to enhance service delivery.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological integration.

Market Segmentation

Portable Diagnostic Devices Type Outlook

Diagnostic Imaging

CT
X-Ray
Ultrasound
Endoscopes

Portable Diagnostic Devices End User Outlook

Hospitals and Clinics
Diagnostic Centers
Homecare Settings
Others

Portable Diagnostic Devices Regional Outlook

North America

US
Canada

Portable Diagnostic Devices Application Outlook

Gynecology
Cardiology
Gastrointestinal
Urology
Neurology
Respiratory
Orthopedics
Ophthalmology
Others

Report Scope

Report Attribute/Metric	Details
Market Size 2035	USD 120.80 billion
Market Size 2032	USD 149.27 billion
Compound Annual Growth Rate (CAGR)	0.00% (2025 - 2035)
Base Year	2024
Forecast Period	2025 - 2035
Historical Data	2020 - 2024
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Diagnosis and Treatment, End User and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Key Companies Profiled	F. Hoffmann-La Roche Ltd, GE Healthcare, Medtronic, Omron Healthcare Inc., Koninklijke Philips N.V., Abbott, SAMSUNGHEALTHCARE.COM, Stryker, Wellue, and EMAY
Key Market Opportunities	Increasing funding and investment through a public and private organizations
Key Market Dynamics	Growing technological advancements Increasing incidences of chronic diseases
Market Size 2024	71.86
Market Size 2025	78.36

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

How much is the portable diagnostic devices market?

The Portable Diagnostic Devices Market is anticipated to reach 149.27 billion at a CAGR of 11.96% during the forecast period of 2023-2032.

How big is the US portable diagnostic devices market?

The US is expected to hold an approx. 82.00% share of the North America market for Portable Diagnostic Devices market during the forecast period of 2023-2032.

What is the growth rate of the Portable Diagnostic Devices market?

The portable diagnostic devices market is expected to grow at an 9.04% cagr during the forecast period from 2023 to 2032.

Which region held the largest market share in the portable diagnostic devices market?

The north American region market held the largest market share in the portable diagnostic devices market.

Who are the key players in the Portable Diagnostic Devices market?

The key players include F. Hoffmann-La Roche Ltd, GE Healthcare, Medtronic, Omron Healthcare Inc., Koninklijke Philips N.V., Abbott, SAMSUNGHEALTHCARE.COM, Stryker, Wellue, and EMAY.

Which end user led the portable diagnostic devices market?

The hospital & clinics was estimated to lead the Portable Diagnostic Devices market.

Table of Contents
Executive Summary
1. OVERVIEW
Market Introduction
1. DEFINITION
2. Scope of the Study
3. RESEARCH OBJECTIVE
4. MARKET STRUCTURE
5. ASSUMPTIONS & LIMITATIONS
Research Methodology
1. DATA MINING
2. SECONDARY RESEARCH
3. PRIMARY RESEARCH
4. BREAKDOWN OF PRIMARY RESPONDENTS
5. FORECASTING TECHNIQUES
6. Research Methodology FOR MARKET SIZE ESTIMATION
  1. Bottom-up Approach
  2. TOP-DOWN APPROACH
7. DATA TRIANGULATION
8. VALIDATION
MARKET DYNAMICS
1. OVERVIEW
2. DRIVERS
  1. GROWING TECHNOLOGICAL ADVANCEMENTS
  2. INCREASING INCIDENCES OF CHRONIC DISEASES
3. RESTRAINTS
  1. LACK OF KNOWLEDGE TO RUN PORTABLE DIAGNOSTIC DEVICES IS A HINDRANCE TO THE MARKET
4. OPPORTUNITIES
  1. INCREASING FUNDING AND INVESTMENT THROUGH A PUBLIC AND PRIVATE ORGANIZATIONS
MARKET FACTOR ANALYSIS
1. VALUE CHAIN ANALYSIS
  1. R&D & DESIGNING
  2. MANUFACTURING
  3. DISTRIBUTION & SALES
  4. POST-SALES MONITORING
2. PORTER''S FIVE FORCES MODEL
  1. THREAT OF NEW ENTRANTS
  2. BARGAINING POWER OF SUPPLIERS
  3. THREAT OF SUBSTITUTES
  4. BARGAINING POWER OF BUYERS
  5. INTENSITY OF RIVALRY
3. IMPACT OF COVID-19 ON THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
  1. IMPACT ON SUPPLY CHAIN
  2. IMPACT ON PRODUCTION
  3. IMPACT ON REGIONS
  4. IMPACT ON SUPPLY GAP ANALYSIS
  5. IMPACT ON PRICING
GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE
1. OVERVIEW
2. DIAGNOSTIC IMAGING
  1. CT Scan
  2. X-Ray
  3. Ultrasound
  4. Endoscopes
3. MONITORING DEVICES
  1. Cardiac Monitoring
  2. Neuromonitoring
  3. Respiratory Monitoring
  4. Ophthalmic Monitoring
  5. Hemodynamic Monitoring Systems
  6. Vital Sign Monitors
  7. Smart Wearable Medical Device
  8. Others
GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION
1. OVERVIEW
2. GYNAECOLOGY
3. CARDIOLOGY
4. GASTROINTESTINAL
5. UROLOGY
6. NEUROLOGY
7. RESPIRATORY
8. ORTHOPEDICS
9. OPTHALMOLOGY
10. OTHERS
GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER
1. OVERVIEW
2. HOSPITALS & CLINICS
3. DIAGNOSTIC CENTERS
4. HOMECARE SETTINGS
5. OTHERS
GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY REGION
1. OVERVIEW
2. GLOBAL
3. NORTH AMERICA
  1. US
  2. CANADA
4. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. REST OF EUROPE
5. ASIA-PACIFIC
  1. CHINA
  2. INDIA
  3. JAPAN
  4. AUSTRALIA
  5. SOUTH KOREA
  6. REST OF ASIA-PACIFIC
6. REST OF THE WORLD
  1. MIDDLE EAST
  2. AFRICA
  3. LATIN AMERICA
Competitive Landscape
1. OVERVIEW
2. COMPETITIVE BENCHMARKING
3. MAJOR GROWTH STRATEGY IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
4. THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
5. KEY DEVELOPMENT ANALYSIS
6. KEY DEVELOPMENTS & GROWTH STRATEGIES
  1. PRODUCT LAUNCH/PRODUCT APPROVAL
  2. PARTNERSHIP/ AGREEMENT/COLLABORATION
7. MAJOR PLAYERS SALES ANALYSIS
  1. SALES & OPERATING INCOME
8. MAJOR PLAYERS R&D ANALYSIS
COMPANY PROFILE
1. F. HOFFMANN-LA ROCHE LTD
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
2. GE HEALTHCARE
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
3. MEDTRONIC
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
4. OMRON HEALTHCARE, INC.
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
5. KONINKLIJKE PHILIPS N.V.
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
6. ABBOTT
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. SWOT ANALYSIS
  6. KEY STRATEGIES
7. SAMSUNGHEALTHCARE.COM
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
8. STRYKER
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
9. WELLUE
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
10. EMAY
  1. COMPANY OVERVIEW
  2. FINANCIAL OVERVIEW
  3. PRODUCTS OFFERED
  4. KEY DEVELOPMENTS
  5. KEY STRATEGIES
List of Tables and Figures
1. LIST OF TABLES
2. TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
3. TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
4. TABLE 3 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
5. TABLE 4 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY REGION, 2019–2032 (USD MILLION)
6. TABLE 5 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
7. TABLE 6 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY REGION, 2019–2032 (USD MILLION)
8. TABLE 7 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
9. TABLE 8 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
10. TABLE 9 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
11. TABLE 10 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
12. TABLE 11 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
13. TABLE 12 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
14. TABLE 13 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR GYNAECOLOGY, BY REGION, 2019–2032 (USD MILLION)
15. TABLE 14 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIOLOGY, BY REGION, 2019–2032 (USD MILLION)
16. TABLE 15 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR GASTROINTESTINAL, BY REGION, 2019–2032 (USD MILLION)
17. TABLE 16 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR UROLOGY, BY REGION, 2019–2032 (USD MILLION)
18. TABLE 17 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROLOGY, BY REGION, 2019–2032 (USD MILLION)
19. TABLE 18 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY, BY REGION, 2019–2032 (USD MILLION)
20. TABLE 19 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR ORTHOPEDICS, BY REGION, 2019–2032 (USD MILLION)
21. TABLE 20 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMOLOGY, BY REGION, 2019–2032 (USD MILLION)
22. TABLE 21 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
23. TABLE 22 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR BY END USER, 2019–2032 (USD MILLION)
24. TABLE 23 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR HOSPITALS & CLINICS, BY REGION 2019–2032 (USD MILLION)
25. TABLE 24 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2032 (USD MILLION)
26. TABLE 25 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR HOMECARE SETTINGS, BY REGION, 2019–2032 (USD MILLION)
27. TABLE 26 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
28. TABLE 27 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY REGION, 2019–2032 (USD MILLION)
29. TABLE 28 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
30. TABLE 29 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
31. TABLE 30 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
32. TABLE 31 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
33. TABLE 32 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
34. TABLE 33 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
35. TABLE 34 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
36. TABLE 35 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
37. TABLE 36 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
38. TABLE 37 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
39. TABLE 38 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
40. TABLE 39 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
41. TABLE 40 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
42. TABLE 41 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
43. TABLE 42 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
44. TABLE 43 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
45. TABLE 44 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
46. TABLE 45 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
47. TABLE 46 NORTH AMERICA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER AMERICAER, 2019–2032 (USD MILLION)
48. TABLE 47 US: PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
49. TABLE 48 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
50. TABLE 49 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
51. TABLE 50 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
52. TABLE 51 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
53. TABLE 52 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
54. TABLE 53 US: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
55. TABLE 54 US: PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
56. TABLE 55 US: PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
57. TABLE 56 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
58. TABLE 57 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
59. TABLE 58 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
60. TABLE 59 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
61. TABLE 60 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
62. TABLE 61 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
63. TABLE 62 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
64. TABLE 63 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
65. TABLE 64 CANADA: PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER, 2019–2032 (USD MILLION)
66. TABLE 65 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
67. TABLE 66 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
68. TABLE 67 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
69. TABLE 68 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
70. TABLE 69 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
71. TABLE 70 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)
72. TABLE 71 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR RESPIRATORY MONITORING, BY TYPE, 2019–2032 (USD MILLION)
73. TABLE 72 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR OPTHALMIC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
74. TABLE 73 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
75. TABLE 74 EUROPE: PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER AMERICAER, 2019–2032 (USD MILLION)
76. TABLE 75 GERMANY: PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE, 2019–2032 (USD MILLION)
77. TABLE 76 GERMANY: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR DIAGNOSTIC IMAGING, BY TYPE, 2019–2032 (USD MILLION)
78. TABLE 77 GERMANY: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR MONITORING DEVICES, BY TYPE, 2019–2032 (USD MILLION)
79. TABLE 78 GERMANY: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR CARDIAC MONITORING, BY TYPE, 2019–2032 (USD MILLION)
80. TABLE 79 GERMANY: PORTABLE DIAGNOSTIC DEVICES MARKET, FOR NEUROMONITORING, BY TYPE, 2019–2032 (USD MILLION)

Portable Diagnostic Devices Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027